Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TP_TRANSPORTER: inhibition of CDF uptake (CDF: 10 uM, Probenecid: 260 uM) in Mrp3-expressing Sf9 cells
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, CA: 500 uM) in membrane vesicles from LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, CA: 500 uM) in membrane vesicles isolated from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, GC: 200 uM) in membrane vesicles from LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, GC: 200 uM) in membrane vesicles isolated from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, TC: 200 uM) in membrane vesicles from LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, TCA: 200 uM) in membrane vesicles isolated from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, TCDC-S: 50 uM) in membrane vesicles isolated from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.055 uM, TLC-S: 20 uM) in membrane vesicles from LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, 4-methylumbeliferone glucuronide: 500 uM) in membrane vesicle from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, DNP-SG: 500 uM) in membrane vesicles from MRP3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, E1S: 500 uM) in membrane vesicle from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, E3040 glucuronide: 50 uM) in membrane vesicles from MRP3-expressing HeLa cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, LTC4: 2.5 uM) in membrane vesicle from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, MTX: 1000 uM) in membrane vesicles from MRP3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, alpha-naphthyl beta-D-glucuronide: 200 uM) in membrane vesicle from Mrp3-expressing LLC-PK1 cells
TP_TRANSPORTER: inhibition of E217betaG uptake in membrane vesicle from MRP3-expressing Sf9 cells
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
TP_TRANSPORTER: inhibition of F-MTX uptake (F-MTX: 5.0 uM, E217betaG: 75.0 uM) in membrane vesicles from IEC-6 cells
TP_TRANSPORTER: inhibition of F-MTX uptake (F-MTX: 5.0 uM, E217betaG: 75.0 uM) in membrane vesicles from Mrp3-Sf9 cells
TP_TRANSPORTER: inhibition of F-MTX uptake (F-MTX: 5.0 uM, MK-571: 100.0 uM) in membrane vesicles from IEC-6 cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on